Analysis of Helicobacter pylori positiveness and upper gastrointestinal system endoscopy results of Yozgat region in Turkey

Yıl 2021, , 901 - 906, 24.09.2021

Tekin Yıldırım , Muhammed Dursun

https://doi.org/10.32322/jhsm.982130

Cited By: 1

Öz

Aims: The aim of this study is to analyze the endoscopy and pathology results of patients who underwent endoscopy in Yozgat region, to determine the frequency of Helicobacter pylori (H. pylori) positivity and to compare the results with the data in the literature.
Material and Method: Among the patients who applied to our clinic for any reason between 01/01/2019 and 31/12/2019, 772 patients who underwent upper gastrointestinal system endoscopy were included in the study and analyzed retrospectively.
Results: The mean age of the patients was 50±16.78 (16–89). 61.3% (n=473) of the patients were female; 38.7% (n=299) were male. When gastroscopic diagnoses were evaluated, the rate of patients reported as "normal upper gastrointestinal endoscopy" was found to be 5.2% (n= 40). The most frequently reported diagnosis was “nonerosive gastritis” with a rate of 59.2% (n=457). Biopsy was obtained in 646 of 772 patients. The most common diagnosis was reported as “chronic active gastritis” with 90.6% (n=585). 626 of the patients had H. pylori pathological evaluation results. While 18.7% (n=117) of the patients were found to be H. pylori negative, 81.3% (n=509) were found to be H. pylori positive. Stomach cancer was found to be 1.3% (n=9) and esophageal cancer was found to be 0.1% (n=1).
Conclusion: In the Yozgat region, the frequency of H. pylori positivity was found to be 81.3%, and it is often mildly (+) positive. In addition, the frequency of H. pylori positivity was similar between men and women, consistent with the literature. The most common diagnosis was reported as "chronic active gastritis". While stomach cancer was detected at a rate of 1.3%, esophageal cancer was found at a rate of 0.1%.

Anahtar Kelimeler

Upper gastrointestinal endoscopy, helicobacter pylori, histopathology, gastric cancer, esophageal cancer

Kaynakça

• Loffeld R, Van der Putten A. The yield of UGIE: a study of a ten-year period in the ‘Zaanstreek’. Neth J Med 2003; 61: 14-8.
• Tamer A, Korkut E, Korkmaz U. Upper gastrointestinal endoscopy results in Düzce region. Med J Kocatepe 2005; 6: 31-4.
• Nur N, Yılmaz A, Yıldız G. Characteristics of patients with gastrointestinal bleeding, evaluation of endoscopy and biopsy results. Journal of the CU Faculty of Medicine 2007; 29: 42-6.
• Kaplan M, Tanoglu A, Düzenli T, Tozun AN. Helicobacter pylori treatment in Turkey: Current status and rational treatment options. North Clin Istanb 2020; 7: 87–94.
• Hunt RH. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes. Scand J Gastroenterol 1996; 31: 3-9.
• Lehours P, Yılmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007; 12: 1-3.
• Yücel T, Aygın D, Sen S, Yücel O. The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 2008; 61: 179-83.
• Malfertheiner P, Megraud F, O'Morain CA on behalf of the European Helicobacter and Microbiota Study Group and Consensus panel, et al Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report Gut 2017; 66: 6-30.
• [No authors listed]. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 6: 1-241.
• McNulty C.A, Lehours P, Mégraud F. Diagnosis of Helicobacter pylori Infection. Helicobacter 2011; 16: 10-18.
• Granstrom M, Lehours P, Bengtsson C, Mégraud, F. Diagnosis of Helicobacter pylori. Helicobacter 2008; 13: 7-12.
• Tonkic A, Tonkic M, Lehours P, Mégraud F. Epidemiology and diagnosis of H. pylori infection. Helicobacter 2012; 17: 1-8.
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
• Gültekin M, Boztaş G, Utku EŞ. Turkey cancer statistics. Eds İ. Şencan, GN İnce T.C. Ministry of Health Turkish Public Health Institution 2016; 19.
• Tuncer İ, Uygan İ, Kösem M, et al. Demographic and histopathological features of upper gastrointestinal system cancers in Van and its surroundings. Van Med J 2001; 8: 10-3.
• Cevheri Ağan Z, Cindoğlu Ç, Ağan V, Uyanıkoğlu A, Yenice N. Analysis of demographic data of patients who underwent esophagogastroduodenoscopy in Harran University Gastroenterology Clinic: 5-year series. Harran University Med J 2019; 16: 101-4.
• Polat Y. Endoscopic experience of a surgeon: The evaluation of 8453 cases. Int J Basic Clin Med 2015; 3: 1-5.
• Coşkun A, Borazan S, Yükselen V et al. Features of upper gastrointestinal tract malignancies in Aydin region. Endoscopy Gastrointestinal 2015; 23: 67-9.
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012. Int J Cancer 2015; 136: 359-86.
• Yalçın B, Zengin N, Aydın F. The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study. Turk J Cancer 2006; 36: 108-15.
• Göçmen E, Kocaoğlu H. Gastric cancer epidemiology. T Klin J Surg 2000; 5: 161-2.
• Kısaoğlu A, Özoğul B, Yıldırgan Mİ, et al. Surgery in stomach cancer: 504 cases. Abant Med J 2014; 3: 220-5.
• Konakcı N, Gülten M, İbanoğlu MS, et al. The frequency of Helicobacter pylori in patients with chronic active gastritis. Journal of Uludag University Medicine Faculty 2010; 36: 7-10.
• Uyanıkoğlu A, Coskun M, Binici DN, et al. The frequency of Helicobacter pylori in patients undergoing endoscopy. Dicle Med J 2012; 39: 197-200.
• Karaaslan H, Bektaş M, Soykan İ, Bozkaya H, Bahar K, Özden A. Helicobacter pylori seroprevalence in volunteer blood donors in Turkey. Türk J Gastroenterol 2003; 14: SBO3/1.
• Göral V, Özdal B, Kaplan A, Şit D, Danış R. Helicobacter pylori antibody prevalence in Diyarbakır province. The Turkish Journal of Academic Gastroenterology 2005; 5: 47-50.
• Bulut M, Armağan E, Kıyıcı M, Balcı V, Atar N, Gürel S. The frequency of Helicobacter pylori in patients presenting to the emergency department with epigastric pain and the role of qualitative serum IgG test in diagnosis. Journal of Uludag University Medicine Faculty 2004; 30: 7-10.
• Özardalı Hİ, Bitiren M, Nazlıgül Y, Yılmaz N. The frequency of Helicobacter pylori in nonerosive gastritis in Şanlıurfa region. Genel Tıp Derg 1998; 8: 149-52.
• Kesli R, Göktürk HS, Erbayrak M, Karabağlı P, Terzi Y. Comparison of the diagnostic values of the 3 different stool antigen tests for the noninvasive diagnosis of Helicobacter pylori infection. J Investig Med 2010; 58: 982-6.
• Korkmaz H, Kesli R, Karabağlı P, Terzi Y. Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection. Helicobacter 2013; 18: 384-91.
• Alim A, Ataş AD, Güneş T, et al. Helicobacter pylori seroprevalence in symptomatic and asymptomatic adults in Sivas province. Journal of the Faculty of Medicine Cumhuriyet University 2004; 26: 75-80.
• Kalem F, Özdemir M, Baysal B. Investigation of the presence of Helicobacter pylori by different methods in patients with dispeptic complaints. Mikrobiyol Bult 2010; 44: 29-34.
• Özdemir M, Baykan M. Investigation of the diagnostic value of H. pylori stool antigen in the diagnosis of H. pylori infection in dyspeptic patients. Genel Tıp Derg 2005; 15: 65-70.
• Arslan D, Tahan F, Demir F, Taşkın İ. Seroprevalence of Helicobacter pylori infection in healthy children admitted to Erciyes University Faculty of Medicine Pediatrics Outpatient Clinic and the factors affecting it. Erciyes Med J 2006; 28: 192-6.
• Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13C-Urea breath test. BMC Public Health 2013; 13: 1215.
• Çiftel S, Okçu N, Dursun H, Albayrak F, Usta S. The frequency of Helicobacter pylori in our region. Güncel Gastroenteroloji, 2016; 20/2: 157-160.
• Dağlı AF, Cihangiroğlu G, Çobanoğlu B, Özercan İH, Bahçecioğlu ih, Özercan MR. The relationship between Helicobacter pylori density and mast cell count in antral gastritis. Fırat Med J 2006; 11: 48-50.
• Megraud F. Epidemiology of Helicobacter pylori infection: Helicobacter pylori. Gastroenterology Clin Nort America 1993; 22: 73-88.
• Ferlay J, Soerjjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: souces, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86.
• Archimandritis A, Spiliadis C, Tzivras M, et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol, 1996; 28: 387-90.
• Güliter S, Keleş H, Özkurt ZN. Kırıkkale University Faculty of Medicine Internal Diseases Clinic Upper Gastrointestinal System Endoscopy Results. KU Faculty of Med J 2004; 6: 10-2.
• Yılmaz N, Bölükbaş C, Bölükbaş F, et al. Our upper gastrointestinal endoscopy findings; Harran University. Turk J Gastroenterol 2003; 14: 198.
• Yükselen V, Öztürk B, Karaoğlu A, et al. Diagnostic distribution of upper gastrointestinal endoscopic examinations performed in Adnan Menderes University Faculty of Medicine, Department of Gastroenterology by years. Turk J Gastroenterol 2003; 14: 489.